Public Policy Letters, Statements, Legal Briefs, & Other Responses
-
ACMG Comments on FDA Draft Guidance for Products Incorporating Genome Editing
-
ACMG Response to Opposing Inclusion of the VALID Act in the FDASLA Act
-
Group Sign-on Letter Concerning the VALID Act of 2022 Discussion Draft
-
ACMG Letter to Michigan Medicaid on Coverage of Prenatal & Carrier Screening
-
ACMG Letter to Indiana Medicaid Supporting Coverage of Prenatal Screening and Testing
-
ACMG Letter of Support for the Right Drug Dose Now Act
-
Group Sign-On Letter Concerning the VA Supremacy Project
-
Group Sign-On Letter Urging CLIAC to Discuss CLIA Modernization
-
Group Sign-On Letter Supporting the VITAL Act
-
Group Sign-on Letter Concerning VA Development of National Standards of Practice